BIOREGENX, INC. cotiza a 0.00 USD y tiene una capitalización bursátil de $4M. En los últimos 12 meses ha facturado $2M con un margen de flujo de caja libre del 1.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BioRegenx, Inc. engages in the research, development, and commercialization of dietary supplements, medical devices, software, and contactless diagnostic technologies in the United States and internationally. The company offers DocSun AI engine, which integrates with a ballistocardiograph that detects an individual's h…
| Métrica | BRGX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 81.1% | 57.0% | +24.0% |
| Operating Margin | -67.1% | -38.6% | -28.5% |
| Net Margin | -83.2% | -33.6% | -49.7% |
| FCF Margin | 1.6% | -13.9% | +15.5% |
| ROE | — | -40.4% | — |
| ROA | -375.6% | -32.0% | -343.6% |
| Current Ratio | 0.06 | 2.84 | -2.78 |
| Debt / Equity | -0.26 | 0.28 | -0.54 |